FHLC holdings
Fidelity MSCI Health Care Index ETF
Positions
337 stored of 337 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 532457108 | 13.346% | $438.9M | Equity (common) | Corporate | United States | USD |
| 2 | Johnson & Johnson | US4781601046 | 478160104 | 8.931% | $293.7M | Equity (common) | Corporate | United States | USD |
| 3 | AbbVie Inc | US00287Y1091 | 00287Y109 | 6.420% | $211.1M | Equity (common) | Corporate | United States | USD |
| 4 | UnitedHealth Group Inc | US91324P1021 | 91324P102 | 5.441% | $178.9M | Equity (common) | Corporate | United States | USD |
| 5 | Merck & Co Inc | US58933Y1055 | 58933Y105 | 4.656% | $153.1M | Equity (common) | Corporate | United States | USD |
| 6 | Thermo Fisher Scientific Inc | US8835561023 | 883556102 | 3.087% | $101.5M | Equity (common) | Corporate | United States | USD |
| 7 | Amgen Inc | US0311621009 | 031162100 | 3.003% | $98.8M | Equity (common) | Corporate | United States | USD |
| 8 | Abbott Laboratories | US0028241000 | 002824100 | 2.663% | $87.6M | Equity (common) | Corporate | United States | USD |
| 9 | Gilead Sciences Inc | US3755581036 | 375558103 | 2.338% | $76.9M | Equity (common) | Corporate | United States | USD |
| 10 | Pfizer Inc | US7170811035 | 717081103 | 2.058% | $67.7M | Equity (common) | Corporate | United States | USD |
| 11 | Bristol-Myers Squibb Co | US1101221083 | 110122108 | 1.929% | $63.4M | Equity (common) | Corporate | United States | USD |
| 12 | CVS Health Corp | US1266501006 | 126650100 | 1.922% | $63.2M | Equity (common) | Corporate | United States | USD |
| 13 | Intuitive Surgical Inc | US46120E6023 | 46120E602 | 1.815% | $59.7M | Equity (common) | Corporate | United States | USD |
| 14 | Danaher Corp | US2358511028 | 235851102 | 1.796% | $59.1M | Equity (common) | Corporate | United States | USD |
| 15 | Vertex Pharmaceuticals Inc | US92532F1003 | 92532F100 | 1.755% | $57.7M | Equity (common) | Corporate | United States | USD |
| 16 | Stryker Corp | US8636671013 | 863667101 | 1.624% | $53.4M | Equity (common) | Corporate | United States | USD |
| 17 | Medtronic PLC | IE00BTN1Y115 | Not reported | 1.586% | $52.2M | Equity (common) | Corporate | Ireland | USD |
| 18 | McKesson Corp | US58155Q1031 | 58155Q103 | 1.517% | $49.9M | Equity (common) | Corporate | United States | USD |
| 19 | Elevance Health Inc | US0367521038 | 036752103 | 1.194% | $39.3M | Equity (common) | Corporate | United States | USD |
| 20 | Regeneron Pharmaceuticals Inc | US75886F1075 | 75886F107 | 1.146% | $37.7M | Equity (common) | Corporate | United States | USD |
| 21 | Cigna Group/The | US1255231003 | 125523100 | 1.064% | $35.0M | Equity (common) | Corporate | United States | USD |
| 22 | Boston Scientific Corp | US1011371077 | 101137107 | 1.005% | $33.0M | Equity (common) | Corporate | United States | USD |
| 23 | HCA Healthcare Inc | US40412C1018 | 40412C101 | 0.911% | $30.0M | Equity (common) | Corporate | United States | USD |
| 24 | Cencora Inc | US03073E1055 | 03073E105 | 0.832% | $27.4M | Equity (common) | Corporate | United States | USD |
| 25 | Cardinal Health Inc | US14149Y1082 | 14149Y108 | 0.783% | $25.7M | Equity (common) | Corporate | United States | USD |
| 26 | Edwards Lifesciences Corp | US28176E1082 | 28176E108 | 0.718% | $23.6M | Equity (common) | Corporate | United States | USD |
| 27 | Becton Dickinson & Co | US0758871091 | 075887109 | 0.683% | $22.5M | Equity (common) | Corporate | United States | USD |
| 28 | IDEXX Laboratories Inc | US45168D1046 | 45168D104 | 0.642% | $21.1M | Equity (common) | Corporate | United States | USD |
| 29 | Humana Inc | US4448591028 | 444859102 | 0.632% | $20.8M | Equity (common) | Corporate | United States | USD |
| 30 | IQVIA Holdings Inc | US46266C1053 | 46266C105 | 0.577% | $19.0M | Equity (common) | Corporate | United States | USD |
| 31 | Agilent Technologies Inc | US00846U1016 | 00846U101 | 0.566% | $18.6M | Equity (common) | Corporate | United States | USD |
| 32 | Waters Corp | US9418481035 | 941848103 | 0.537% | $17.7M | Equity (common) | Corporate | United States | USD |
| 33 | Natera Inc | US6323071042 | 632307104 | 0.522% | $17.2M | Equity (common) | Corporate | United States | USD |
| 34 | Zoetis Inc | US98978V1035 | 98978V103 | 0.470% | $15.5M | Equity (common) | Corporate | United States | USD |
| 35 | Dexcom Inc | US2521311074 | 252131107 | 0.465% | $15.3M | Equity (common) | Corporate | United States | USD |
| 36 | GE HealthCare Technologies Inc | US36266G1076 | 36266G107 | 0.449% | $14.8M | Equity (common) | Corporate | United States | USD |
| 37 | ResMed Inc | US7611521078 | 761152107 | 0.445% | $14.6M | Equity (common) | Corporate | United States | USD |
| 38 | Centene Corp | US15135B1017 | 15135B101 | 0.443% | $14.6M | Equity (common) | Corporate | United States | USD |
| 39 | Illumina Inc | US4523271090 | 452327109 | 0.442% | $14.6M | Equity (common) | Corporate | United States | USD |
| 40 | Revolution Medicines Inc | US76155X1000 | 76155X100 | 0.439% | $14.4M | Equity (common) | Corporate | United States | USD |
| 41 | Veeva Systems Inc | US9224751084 | 922475108 | 0.433% | $14.3M | Equity (common) | Corporate | United States | USD |
| 42 | Biogen Inc | US09062X1037 | 09062X103 | 0.431% | $14.2M | Equity (common) | Corporate | United States | USD |
| 43 | Mettler-Toledo International Inc | US5926881054 | 592688105 | 0.417% | $13.7M | Equity (common) | Corporate | United States | USD |
| 44 | Alnylam Pharmaceuticals Inc | US02043Q1076 | 02043Q107 | 0.394% | $13.0M | Equity (common) | Corporate | United States | USD |
| 45 | Quest Diagnostics Inc | US74834L1008 | 74834L100 | 0.371% | $12.2M | Equity (common) | Corporate | United States | USD |
| 46 | Labcorp Holdings Inc | US5049221055 | 504922105 | 0.369% | $12.1M | Equity (common) | Corporate | United States | USD |
| 47 | West Pharmaceutical Services Inc | US9553061055 | 955306105 | 0.355% | $11.7M | Equity (common) | Corporate | United States | USD |
| 48 | Royalty Pharma PLC | GB00BMVP7Y09 | Not reported | 0.348% | $11.4M | Equity (common) | Corporate | United Kingdom | USD |
| 49 | STERIS PLC | IE00BFY8C754 | Not reported | 0.323% | $10.6M | Equity (common) | Corporate | Ireland | USD |
| 50 | Tenet Healthcare Corp | US88033G4073 | 88033G407 | 0.321% | $10.6M | Equity (common) | Corporate | United States | USD |
| 51 | Insmed Inc | US4576693075 | 457669307 | 0.300% | $9.9M | Equity (common) | Corporate | United States | USD |
| 52 | Viatris Inc | US92556V1061 | 92556V106 | 0.296% | $9.7M | Equity (common) | Corporate | United States | USD |
| 53 | United Therapeutics Corp | US91307C1027 | 91307C102 | 0.296% | $9.7M | Equity (common) | Corporate | United States | USD |
| 54 | Incyte Corp | US45337C1027 | 45337C102 | 0.293% | $9.6M | Equity (common) | Corporate | United States | USD |
| 55 | Guardant Health Inc | US40131M1099 | 40131M109 | 0.285% | $9.4M | Equity (common) | Corporate | United States | USD |
| 56 | Moderna Inc | US60770K1079 | 60770K107 | 0.266% | $8.8M | Equity (common) | Corporate | United States | USD |
| 57 | Zimmer Biomet Holdings Inc | US98956P1021 | 98956P102 | 0.262% | $8.6M | Equity (common) | Corporate | United States | USD |
| 58 | Neurocrine Biosciences Inc | US64125C1099 | 64125C109 | 0.230% | $7.5M | Equity (common) | Corporate | United States | USD |
| 59 | Roivant Sciences Ltd | BMG762791017 | Not reported | 0.228% | $7.5M | Equity (common) | Corporate | Bermuda | USD |
| 60 | Medline Inc | US58507V1070 | 58507V107 | 0.209% | $6.9M | Equity (common) | Corporate | United States | USD |
| 61 | Cooper Cos Inc/The | US2166485019 | 216648501 | 0.204% | $6.7M | Equity (common) | Corporate | United States | USD |
| 62 | Jazz Pharmaceuticals PLC | IE00B4Q5ZN47 | Not reported | 0.202% | $6.7M | Equity (common) | Corporate | Ireland | USD |
| 63 | Baxter International Inc | US0718131099 | 071813109 | 0.195% | $6.4M | Equity (common) | Corporate | United States | USD |
| 64 | Elanco Animal Health Inc | US28414H1032 | 28414H103 | 0.191% | $6.3M | Equity (common) | Corporate | United States | USD |
| 65 | Medpace Holdings Inc | US58506Q1094 | 58506Q109 | 0.191% | $6.3M | Equity (common) | Corporate | United States | USD |
| 66 | Solventum Corp | US83444M1018 | 83444M101 | 0.182% | $6.0M | Equity (common) | Corporate | United States | USD |
| 67 | Revvity Inc | US7140461093 | 714046109 | 0.182% | $6.0M | Equity (common) | Corporate | United States | USD |
| 68 | Exelixis Inc | US30161Q1040 | 30161Q104 | 0.180% | $5.9M | Equity (common) | Corporate | United States | USD |
| 69 | Penumbra Inc | US70975L1070 | 70975L107 | 0.173% | $5.7M | Equity (common) | Corporate | United States | USD |
| 70 | Bridgebio Pharma Inc | US10806X1028 | 10806X102 | 0.170% | $5.6M | Equity (common) | Corporate | United States | USD |
| 71 | Align Technology Inc | US0162551016 | 016255101 | 0.167% | $5.5M | Equity (common) | Corporate | United States | USD |
| 72 | Charles River Laboratories International Inc | US1598641074 | 159864107 | 0.166% | $5.5M | Equity (common) | Corporate | United States | USD |
| 73 | Insulet Corp | US45784P1012 | 45784P101 | 0.165% | $5.4M | Equity (common) | Corporate | United States | USD |
| 74 | Bio-Techne Corp | US09073M1045 | 09073M104 | 0.163% | $5.4M | Equity (common) | Corporate | United States | USD |
| 75 | Encompass Health Corp | US29261A1007 | 29261A100 | 0.159% | $5.2M | Equity (common) | Corporate | United States | USD |
| 76 | Corcept Therapeutics Inc | US2183521028 | 218352102 | 0.159% | $5.2M | Equity (common) | Corporate | United States | USD |
| 77 | BioMarin Pharmaceutical Inc | US09061G1013 | 09061G101 | 0.154% | $5.1M | Equity (common) | Corporate | United States | USD |
| 78 | State Street Global Advisors State Street Institutional Treasury Plus Money Market Fund | US8574928623 | 857492862 | 0.149% | $4.9M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 79 | Molina Healthcare Inc | US60855R1005 | 60855R100 | 0.148% | $4.9M | Equity (common) | Corporate | United States | USD |
| 80 | Ensign Group Inc/The | US29358P1012 | 29358P101 | 0.148% | $4.9M | Equity (common) | Corporate | United States | USD |
| 81 | Arrowhead Pharmaceuticals Inc | US04280A1007 | 04280A100 | 0.146% | $4.8M | Equity (common) | Corporate | United States | USD |
| 82 | Halozyme Therapeutics Inc | US40637H1095 | 40637H109 | 0.142% | $4.7M | Equity (common) | Corporate | United States | USD |
| 83 | Glaukos Corp | US3773221029 | 377322102 | 0.133% | $4.4M | Equity (common) | Corporate | United States | USD |
| 84 | Avantor Inc | US05352A1007 | 05352A100 | 0.131% | $4.3M | Equity (common) | Corporate | United States | USD |
| 85 | Globus Medical Inc | US3795772082 | 379577208 | 0.129% | $4.2M | Equity (common) | Corporate | United States | USD |
| 86 | BrightSpring Health Services Inc | US10950A1060 | 10950A106 | 0.125% | $4.1M | Equity (common) | Corporate | United States | USD |
| 87 | Axsome Therapeutics Inc | US05464T1043 | 05464T104 | 0.125% | $4.1M | Equity (common) | Corporate | United States | USD |
| 88 | Universal Health Services Inc | US9139031002 | 913903100 | 0.124% | $4.1M | Equity (common) | Corporate | United States | USD |
| 89 | Cytokinetics Inc | US23282W6057 | 23282W605 | 0.124% | $4.1M | Equity (common) | Corporate | United States | USD |
| 90 | HealthEquity Inc | US42226A1079 | 42226A107 | 0.123% | $4.0M | Equity (common) | Corporate | United States | USD |
| 91 | Henry Schein Inc | US8064071025 | 806407102 | 0.122% | $4.0M | Equity (common) | Corporate | United States | USD |
| 92 | Ionis Pharmaceuticals Inc | US4622221004 | 462222100 | 0.117% | $3.9M | Equity (common) | Corporate | United States | USD |
| 93 | DaVita Inc | US23918K1088 | 23918K108 | 0.116% | $3.8M | Equity (common) | Corporate | United States | USD |
| 94 | Alkermes PLC | IE00B56GVS15 | Not reported | 0.112% | $3.7M | Equity (common) | Corporate | Ireland | USD |
| 95 | TG Therapeutics Inc | US88322Q1085 | 88322Q108 | 0.111% | $3.7M | Equity (common) | Corporate | United States | USD |
| 96 | Crinetics Pharmaceuticals Inc | US22663K1079 | 22663K107 | 0.111% | $3.6M | Equity (common) | Corporate | United States | USD |
| 97 | Repligen Corp | US7599161095 | 759916109 | 0.106% | $3.5M | Equity (common) | Corporate | United States | USD |
| 98 | Praxis Precision Medicines Inc | US74006W2070 | 74006W207 | 0.102% | $3.4M | Equity (common) | Corporate | United States | USD |
| 99 | Krystal Biotech Inc | US5011471027 | 501147102 | 0.102% | $3.3M | Equity (common) | Corporate | United States | USD |
| 100 | Protagonist Therapeutics Inc | US74366E1029 | 74366E102 | 0.101% | $3.3M | Equity (common) | Corporate | United States | USD |